nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—HSD17B6—ovarian cancer	0.0797	0.198	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—PPP1CC—ovarian cancer	0.0686	0.17	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—CAV1—ovarian cancer	0.0223	0.0553	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Altretamine—ovarian cancer	0.0211	0.0353	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Altretamine—ovarian cancer	0.0209	0.0351	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Altretamine—ovarian cancer	0.0174	0.0292	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Altretamine—ovarian cancer	0.0161	0.0269	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Altretamine—ovarian cancer	0.0154	0.0258	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Altretamine—ovarian cancer	0.0144	0.0241	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HSD17B6—ovarian cancer	0.0101	0.0251	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.0098	0.0244	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Topotecan—ovarian cancer	0.00942	0.0158	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Paclitaxel—ovarian cancer	0.00822	0.0138	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CHMP4C—ovarian cancer	0.00809	0.0201	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Vinorelbine—ovarian cancer	0.00805	0.0135	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NME2—ovarian cancer	0.00775	0.0193	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Chlorambucil—ovarian cancer	0.0076	0.0127	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Topotecan—ovarian cancer	0.00754	0.0126	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Chlorambucil—ovarian cancer	0.0075	0.0126	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00745	0.0125	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Chlorambucil—ovarian cancer	0.00744	0.0125	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HSD17B6—ovarian cancer	0.00709	0.0176	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00706	0.0118	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—BCL9—ovarian cancer	0.00702	0.0174	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain upper—Docetaxel—ovarian cancer	0.00696	0.0117	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Chlorambucil—ovarian cancer	0.00682	0.0114	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Topotecan—ovarian cancer	0.00676	0.0113	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Topotecan—ovarian cancer	0.00668	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00663	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Topotecan—ovarian cancer	0.00663	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Melphalan—ovarian cancer	0.00662	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00658	0.0163	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Melphalan—ovarian cancer	0.00654	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Melphalan—ovarian cancer	0.0065	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Melphalan—ovarian cancer	0.00649	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Vinorelbine—ovarian cancer	0.00645	0.0108	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Topotecan—ovarian cancer	0.00628	0.0105	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Chlorambucil—ovarian cancer	0.00619	0.0104	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Topotecan—ovarian cancer	0.00607	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DLC1—ovarian cancer	0.00603	0.015	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Chlorambucil—ovarian cancer	0.00591	0.00989	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Vinorelbine—ovarian cancer	0.00571	0.00957	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00568	0.0095	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Vinorelbine—ovarian cancer	0.00567	0.00949	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Topotecan—ovarian cancer	0.00551	0.00923	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Chlorambucil—ovarian cancer	0.00549	0.00919	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Paclitaxel—ovarian cancer	0.00542	0.00907	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Melphalan—ovarian cancer	0.0054	0.00904	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00538	0.009	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00536	0.0133	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Paclitaxel—ovarian cancer	0.00534	0.00894	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Topotecan—ovarian cancer	0.00526	0.0088	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PPP1CC—ovarian cancer	0.00521	0.013	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Vinorelbine—ovarian cancer	0.0052	0.0087	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Melphalan—ovarian cancer	0.00515	0.00862	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Chlorambucil—ovarian cancer	0.00513	0.00858	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Topotecan—ovarian cancer	0.00508	0.00851	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYTB—ovarian cancer	0.005	0.0124	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BCL9—ovarian cancer	0.00491	0.0122	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Topotecan—ovarian cancer	0.00489	0.00818	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.00488	0.0121	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Topotecan—ovarian cancer	0.00485	0.00811	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Topotecan—ovarian cancer	0.00484	0.0081	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Topotecan—ovarian cancer	0.00481	0.00806	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Melphalan—ovarian cancer	0.00478	0.00801	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Melphalan—ovarian cancer	0.00474	0.00794	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Melphalan—ovarian cancer	0.00474	0.00793	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Vinorelbine—ovarian cancer	0.00472	0.00789	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Epirubicin—ovarian cancer	0.0047	0.00786	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Docetaxel—ovarian cancer	0.00459	0.00769	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Topotecan—ovarian cancer	0.00456	0.00764	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Vinorelbine—ovarian cancer	0.0045	0.00753	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Melphalan—ovarian cancer	0.00447	0.00748	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—BRIP1—ovarian cancer	0.00437	0.0108	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPP1CC—ovarian cancer	0.00437	0.0108	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Vinorelbine—ovarian cancer	0.00435	0.00728	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00435	0.00728	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Paclitaxel—ovarian cancer	0.00434	0.00726	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Vinorelbine—ovarian cancer	0.00418	0.007	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Vinorelbine—ovarian cancer	0.00414	0.00694	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Vinorelbine—ovarian cancer	0.00414	0.00693	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Vinorelbine—ovarian cancer	0.00412	0.00689	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HDAC6—ovarian cancer	0.00395	0.00981	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Vinorelbine—ovarian cancer	0.0039	0.00654	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Paclitaxel—ovarian cancer	0.00389	0.00651	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DOK1—ovarian cancer	0.00388	0.00965	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Paclitaxel—ovarian cancer	0.00384	0.00643	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00382	0.00639	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Paclitaxel—ovarian cancer	0.00381	0.00638	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Docetaxel—ovarian cancer	0.00368	0.00615	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PPP1CC—ovarian cancer	0.00365	0.00907	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00362	0.00605	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Paclitaxel—ovarian cancer	0.0035	0.00585	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—XIAP—ovarian cancer	0.00343	0.00851	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SMARCA4—ovarian cancer	0.00334	0.00829	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Docetaxel—ovarian cancer	0.0033	0.00552	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—EREG—ovarian cancer	0.00326	0.00809	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Docetaxel—ovarian cancer	0.00326	0.00545	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00324	0.00542	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Docetaxel—ovarian cancer	0.00323	0.00541	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.00318	0.0079	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Paclitaxel—ovarian cancer	0.00317	0.00531	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Epirubicin—ovarian cancer	0.0031	0.00518	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00306	0.00513	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Epirubicin—ovarian cancer	0.00305	0.00511	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Paclitaxel—ovarian cancer	0.00303	0.00506	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Docetaxel—ovarian cancer	0.00296	0.00496	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—YAP1—ovarian cancer	0.00293	0.00727	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Paclitaxel—ovarian cancer	0.00292	0.00489	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.0029	0.0072	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Doxorubicin—ovarian cancer	0.00287	0.0048	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FASN—ovarian cancer	0.00285	0.00708	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PARP1—ovarian cancer	0.00284	0.00705	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Doxorubicin—ovarian cancer	0.00282	0.00473	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Paclitaxel—ovarian cancer	0.00281	0.00471	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Paclitaxel—ovarian cancer	0.00279	0.00467	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Paclitaxel—ovarian cancer	0.00279	0.00466	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Paclitaxel—ovarian cancer	0.00277	0.00464	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HDAC6—ovarian cancer	0.00277	0.00687	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC2A1—ovarian cancer	0.00271	0.00673	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Docetaxel—ovarian cancer	0.00269	0.0045	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Paclitaxel—ovarian cancer	0.00263	0.0044	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Docetaxel—ovarian cancer	0.00256	0.00429	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.00255	0.00633	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Epirubicin—ovarian cancer	0.00248	0.00415	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Docetaxel—ovarian cancer	0.00248	0.00415	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—YAP1—ovarian cancer	0.00245	0.00608	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—XIAP—ovarian cancer	0.0024	0.00596	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—FASN—ovarian cancer	0.00239	0.00593	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Docetaxel—ovarian cancer	0.00238	0.00399	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Docetaxel—ovarian cancer	0.00236	0.00396	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Docetaxel—ovarian cancer	0.00236	0.00395	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC5A5—ovarian cancer	0.00235	0.00583	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Docetaxel—ovarian cancer	0.00235	0.00393	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SMARCA4—ovarian cancer	0.00234	0.00581	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PPP2R1A—ovarian cancer	0.0023	0.00572	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Doxorubicin—ovarian cancer	0.00229	0.00384	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EREG—ovarian cancer	0.00228	0.00567	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC2A1—ovarian cancer	0.00227	0.00563	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Docetaxel—ovarian cancer	0.00223	0.00373	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Epirubicin—ovarian cancer	0.00223	0.00372	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.00222	0.00552	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Epirubicin—ovarian cancer	0.0022	0.00368	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00218	0.00365	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Epirubicin—ovarian cancer	0.00218	0.00365	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP1B1—ovarian cancer	0.00217	0.0054	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PGR—ovarian cancer	0.00214	0.00531	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00207	0.00346	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Doxorubicin—ovarian cancer	0.00206	0.00345	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Doxorubicin—ovarian cancer	0.00203	0.0034	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00202	0.00338	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Doxorubicin—ovarian cancer	0.00202	0.00338	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Epirubicin—ovarian cancer	0.002	0.00334	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PARP1—ovarian cancer	0.00199	0.00494	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPP2R1A—ovarian cancer	0.00193	0.00479	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.00192	0.00477	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00191	0.0032	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Doxorubicin—ovarian cancer	0.00185	0.00309	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—TERT—ovarian cancer	0.00183	0.00454	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Epirubicin—ovarian cancer	0.00181	0.00304	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCB1—ovarian cancer	0.00179	0.00445	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TYMS—ovarian cancer	0.00176	0.00437	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Epirubicin—ovarian cancer	0.00173	0.0029	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CAV1—ovarian cancer	0.00169	0.0042	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Doxorubicin—ovarian cancer	0.00168	0.00281	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Epirubicin—ovarian cancer	0.00167	0.0028	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PPP2R1A—ovarian cancer	0.00161	0.00401	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Epirubicin—ovarian cancer	0.00161	0.00269	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6ST—ovarian cancer	0.0016	0.00398	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Doxorubicin—ovarian cancer	0.0016	0.00268	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Epirubicin—ovarian cancer	0.00159	0.00267	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Epirubicin—ovarian cancer	0.00159	0.00267	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Epirubicin—ovarian cancer	0.00158	0.00265	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Doxorubicin—ovarian cancer	0.00155	0.00259	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—APC—ovarian cancer	0.00154	0.00383	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Epirubicin—ovarian cancer	0.0015	0.00251	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Doxorubicin—ovarian cancer	0.00149	0.00249	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Doxorubicin—ovarian cancer	0.00147	0.00247	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Doxorubicin—ovarian cancer	0.00147	0.00247	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Doxorubicin—ovarian cancer	0.00147	0.00245	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CAV1—ovarian cancer	0.00142	0.00352	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Doxorubicin—ovarian cancer	0.00139	0.00233	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CD—ovarian cancer	0.00135	0.00337	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.00135	0.00336	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CG—ovarian cancer	0.00129	0.00321	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TERT—ovarian cancer	0.00128	0.00318	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERBB2—ovarian cancer	0.0012	0.00297	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CAV1—ovarian cancer	0.00118	0.00294	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CB—ovarian cancer	0.00118	0.00293	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTOR—ovarian cancer	0.00118	0.00293	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ESR1—ovarian cancer	0.00114	0.00284	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CD—ovarian cancer	0.00113	0.00282	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6ST—ovarian cancer	0.00112	0.00279	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1B—ovarian cancer	0.00111	0.00275	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APC—ovarian cancer	0.00108	0.00268	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CG—ovarian cancer	0.00108	0.00268	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CTNNB1—ovarian cancer	0.00105	0.0026	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTEN—ovarian cancer	0.00102	0.00253	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CB—ovarian cancer	0.000989	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CD—ovarian cancer	0.000949	0.00236	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT3—ovarian cancer	0.000913	0.00227	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NRAS—ovarian cancer	0.00091	0.00226	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MAPK3—ovarian cancer	0.000872	0.00217	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTEN—ovarian cancer	0.000855	0.00212	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MYC—ovarian cancer	0.000848	0.00211	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ERBB2—ovarian cancer	0.000838	0.00208	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MAPK1—ovarian cancer	0.00083	0.00206	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EGFR—ovarian cancer	0.000829	0.00206	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MTOR—ovarian cancer	0.000827	0.00205	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CB—ovarian cancer	0.000827	0.00205	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL8—ovarian cancer	0.000795	0.00197	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KRAS—ovarian cancer	0.000784	0.00195	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1B—ovarian cancer	0.000776	0.00193	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASP3—ovarian cancer	0.000761	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL2—ovarian cancer	0.000759	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCND1—ovarian cancer	0.00074	0.00184	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CTNNB1—ovarian cancer	0.000733	0.00182	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CA—ovarian cancer	0.00072	0.00179	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—ovarian cancer	0.000719	0.00179	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTEN—ovarian cancer	0.000715	0.00177	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HRAS—ovarian cancer	0.000666	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—ovarian cancer	0.000645	0.0016	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT3—ovarian cancer	0.000639	0.00159	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NRAS—ovarian cancer	0.000638	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—ovarian cancer	0.000637	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK3—ovarian cancer	0.000611	0.00152	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CA—ovarian cancer	0.000603	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MYC—ovarian cancer	0.000594	0.00148	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—ovarian cancer	0.000588	0.00146	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK1—ovarian cancer	0.000581	0.00144	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGFR—ovarian cancer	0.000581	0.00144	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KRAS—ovarian cancer	0.000549	0.00136	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CA—ovarian cancer	0.000504	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—ovarian cancer	0.000493	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TP53—ovarian cancer	0.000488	0.00121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HRAS—ovarian cancer	0.000466	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—ovarian cancer	0.000446	0.00111	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—ovarian cancer	0.000412	0.00102	CbGpPWpGaD
